Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin and Tranexamic Acid for Blood Loss in Scoliosis Surgery
NCT02084342Unknown
- Start
- Dec 2013
- Primary completion
- Apr 2014
- Modality
- Peptides, Small Molecules
01
Overview
Randomised, double-blind trial of desmopressin (2 arms). Primary endpoint: Blood Loss. Status: unknown.
02
Drugs
desmopressin
Beyond the preview
Go deeper on NCT02084342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084342.